Marion Dorsch
President at Atavistik Bio, Inc.
Marion Dorsch active positions
| Companies | Position | Start | End |
|---|---|---|---|
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Chief Tech/Sci/R&D Officer | 01/04/2021 | - |
| President | 01/04/2021 | - |
Career history of Marion Dorsch
Former positions of Marion Dorsch
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 21/11/2016 | 01/03/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2012 | 01/11/2016 |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01/01/2010 | 01/04/2012 |
Training of Marion Dorsch
| Freie Universität Berlin | Doctorate Degree |
Statistics
International
| United States | 4 |
| Germany | 2 |
| France | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Marion Dorsch
- Experience
